A. Elder

发表

Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).

C. Zhang, S. Ghosh, B. Jaffee, 2006, Journal of medicinal chemistry.

The Role of Fluorine in the Discovery and Optimization of CNS Agents: Modulation of Drug-Like Properties

G. Harriman, A. Elder, K. Hodgetts, 2010 .

Reversed binding of a small molecule ligand in homologous chemokine receptors – differential role of extracellular loop 2

T. Frimurer, M. Rosenkilde, R. Kolbeck, 2012, British journal of pharmacology.

Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).

S. Ghosh, K. Burke, O. Tayber, 2005, Prostaglandins & other lipid mediators.

Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models

Graham T Dempsey, L. Galluzzi, Luis A. Williams, 2022, Molecular therapy. Nucleic acids.

Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905).

Courtney A. Cullis, Mansoureh Rezaei, M. Sintchak, 2012, Journal of medicinal chemistry.

Two syntheses of the 16- and 17-membered DEF ring systems of chloropeptin and complestatin.

D. Rich, A. Elder, 1999, Organic letters.

Synthesis of 3-amino-1,2,4-benzothiadi- azine 1,1-dioxides via a tandem aza-Wittig/heterocumulene annulation.

S. Ghosh, C. Blackburn, G. Harriman, 2005, The Journal of organic chemistry.

Tandem Michael addition and azanorbornane substance-P antagonists

P. Thadeio, S. Mclean, A. Elder, 1997 .

Synthesis of model systems of the complement inhibitors, complestatin and chloropeptin

D. Rich, A. Elder, 2002 .

Molecular Interaction of a Potent Nonpeptide Agonist with the Chemokine Receptor CCR8

T. Schwartz, M. Rosenkilde, S. Ghosh, 2007, Molecular Pharmacology.

Medicinal Chemistry of the Optimization of Enzyme Inhibitors

G. Harriman, A. Elder, Indranath Ghosh, 2010 .